Brandywine Global Investment Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,279
Closed -$4.45M 825
2019
Q3
$4.45M Sell
13,279
-17,543
-57% -$5.62M 0.03% 413
2019
Q2
$8.01M Buy
30,822
+11,626
+61% +$2.33M 0.06% 292
2019
Q1
$3.17M Buy
+19,196
New +$3.12M 0.02% 462

Other funds holding CDLX

Brandywine Global Investment Management's CDLX Position: Q4 2019 in Review

Brandywine Global Investment Management sold out of Cardlytics (CDLX) in Q4 2019, closing a stake of 13,279 shares — an estimated $4.45M sold.

Brandywine Global Investment Management first reported a position in CDLX in Q1 2019 and held it in 3 quarters. The position peaked at $8.01M in Q2 2019. 156 funds tracked by Wall St. Rank hold CDLX as of Q4 2019.

  • Brandywine Global Investment Management reported no remaining Cardlytics position as of Q4 2019 after selling out during the quarter.
  • Brandywine Global Investment Management sold 13,279 Cardlytics shares in Q4 2019, an estimated $4.45M.
  • Brandywine Global Investment Management first reported a position in Cardlytics in Q1 2019 and held it in 3 quarters.
  • Brandywine Global Investment Management's Cardlytics position peaked at $8.01M in Q2 2019.
  • 156 funds tracked by Wall St. Rank held Cardlytics as of Q4 2019.

Based on Brandywine Global Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.